Natural compound rosmarinic acid displays anti-tumor activity in colorectal cancer cells by suppressing nuclear factor-kappa B signaling
Authors:
Open Access
- 24 May 2025
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 16 (5) , 105341
Abstract
BACKGROUND Rosmarinic acid (RA) is a natural polyphenol carboxylic acid known for its role in chemoprevention. Given its widespread use as a food additive, we are interested in whether RA affects the development of colorectal cancer (CRC). AIM To examine the anti-tumor effects of RA on various CRC cell lines, and to further investigate the possible mechanisms. METHODS Cell Counting Kit-8 assay and optical microscopy imaging were used to evaluate the viability of CRC cell lines. Western blot, quantitative real-time polymerase chain reaction, and flow cytometry analyses were performed to assess cell viability and activation of nuclear factor-kappa B (NF-κB) signaling. Molecular modeling was used to assess the interaction between RA and inhibitory kappa B kinase beta. Luciferase assay was used to examine the activity of NF-κB-driven transcription. The combinations of RA with 5-fluorouracil or oxaliplatin were utilized to evaluate the potential synergistic action of RA with the chemotherapeutics. RESULTS RA exerted potent cytotoxic actions on all six CRC cell lines examined. RA was docked nicely into the binding pocket of inhibitory kappa B kinase beta by molecular modeling. The activity of NF-κB-driven luciferase and the phosphorylation of NF-κB p65 were decreased after exposure to the compound. Lipopolysaccharide-induced NF-κB activation was effectively inhibited by RA, too. Further, RA downregulated the expression of cell proliferation-related cyclin D1 and MYC, which are target genes of NF-κB. Of note, the cytotoxic actions of 5-fluorouracil and oxaliplatin were markedly enhanced by RA in those CRC cells. CONCLUSION Our results indicate that RA inhibits NF-κB signaling and induces apoptosis in CRC cells. It enhances the cytotoxic actions of chemotherapeutics and might help to improve the chemotherapy of CRC.Keywords
This publication has 24 references indexed in Scilit:
- Rosmarinic acid attenuates glioblastoma cells and spheroids’ growth and EMT/stem-like state by PTEN/PI3K/AKT downregulation and ERK-induced apoptosisPhytomedicine, 2024
- Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatmentsCancer and Metastasis Reviews, 2023
- Rosmarinic acid, the active component of Rubi Fructus, induces apoptosis of SGC-7901 and HepG2 cells through mitochondrial pathway and exerts anti-tumor effectNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Colon cancer and colorectal cancer: Prevention and treatment by potential natural productsChemico-Biological Interactions, 2022
- Anxiolytic and antidepressive potentials of rosmarinic acid: A review with a focus on antioxidant and anti-inflammatory effectsPharmacological Research, 2022
- Curcumin and colorectal cancer: An update and current perspective on this natural medicineSeminars in Cancer Biology, 2022
- Colorectal CancerSurgical Oncology Clinics of North America, 2022
- Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axisNeoplasia, 2021
- TRAF6 promotes the progression and growth of colorectal cancer through nuclear shuttle regulation NF-kB/c-jun signaling pathwayLife Sciences, 2019
- PAX6, a Novel Target of microRNA-7, Promotes Cellular Proliferation and Invasion in Human Colorectal Cancer CellsDigestive Diseases and Sciences, 2013